期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

慢性心房颤动的治疗 被引量：5

Treatment of chronic atrial fibrillation
下载PDF
导出
摘要 慢性心房颤动(房颤)的治疗主要是针对其快速心率和卒中/栓塞潜在危险,包括心率控制、抗栓治疗和尝试恢复窦性心律。虽然导管消融术可使部分慢性房颤患者恢复窦性心律,但是尚缺乏足够临床证据准确评价其疗效。因此,对于大部分慢性房颤患者,应严格遵循房颤治疗指南建议,积极控制心率,加强抗血栓治疗。 Chronic atrial fibrillation （AF） treatment is mainly tor the potential ciangers ot raplo heart rate anu stroke/embolism, including heart rate control, antithrombotic treatment and restoration of sinus rhythm. Although catheter ablation can induce some patients with chronic AF to restore sinus rhythm, there has been no sufficient clinical evidence to accurately evaluate its efficacy. Therefore, the treatment for the majority of patients with chronic AF should strictly follow the recommendations of AF treatment guidelines, actively controlling heart rate and strengthening antithrombotic therapy.
作者 王业松
机构地区 中山大学附属第一医院心内科
出处 《新医学》 2013年第1期3-7,共5页 Journal of New Medicine
关键词 慢性心房颤动 心率控制 抗栓治疗 Chronic atrial fibrillation Heart rate control Antithrombotic therapy
分类号 R541.75 [医药卫生—心血管疾病]
  • 相关文献

参考文献15

  • 1Fuster V, Ryd6n LE, Cannom DS, et al. ACC/AHA/ ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiol- ogy Committee for Practice Guidelines (Writing Commit- tee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) . Circulation, 2006, 114: e257-e354.
  • 2Van Gelder IC, Groenveld HF, Crijns HJ, et al. Leni- ent versus strict rate control in patients with atrial fibril- lation. N Engl J Med, 2010, 362: 1363-1373.
  • 3European Heart Rhythm Association, European Associ- ation for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) . Europace, 2010, 12: 1360-1420.
  • 4Wann LS, Curtis AB, January CT, et al. 2011 ACCF! AHA/HRS focused update on the management of pa- tients with atrial fibrillation (Updating the 2006 Guide- line) : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2011, 123: 104- 123.
  • 5陈翔,秦永文.关注心房颤动的药物治疗[J].新医学,2009,40(11):701-704. 被引量：7
  • 6Authors/Task Force Members, Camm ALl, Lip GY, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the Euro- pean Heart Rhythm Association. Eur Heart J, 2012, 24.
  • 7Connolly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events ( ACTIVE W) : a random- ised controlled trial. Lancet. 2006. 367, 1903-1912.
  • 8Connolly SJ, Pogue J, Hart RG, et al. Effect of clopi- dogrel added to aspirin in patients with atrial fibrillation. N Engl J Med, 2009, 360: 2066-2078.
  • 9Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med, 2009, 361: 1139-1151.
  • 10Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med, 2011, 365: 883-891.

二级参考文献18

  • 1刘积伦,周梦琳,武胜,王群让,周晓林.卡托普利联合胺碘酮治疗阵发性心房颤动的临床研究——附44例报告[J].新医学,2006,37(6):370-372. 被引量：3
  • 2EUROPEAN HEART RHYTHM ASSOCIATION, HEART RHYTHM SOCIETY, FUSTER V, et al. ACC/AHA/ ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: a report of the American College of Cardiology/American Heart Associa- tion Task Force on Practice Guidelines and the European Society of Cardiology, Committee for Practice Guidelines ( Writing Committee to Revise the 2001 Guidelines for the Management of Patients Wilh Atrial Fibrillation) [J].J Am Coll Cardiol, 2006, 48 (4) : 854-906.
  • 3WYSE D G, WALDO A L, DIMARCO J P, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation [ J ]. N Engl J Med, 2002, 347 (23) : 1825-1833.
  • 4DAHLOF B, DEVEREUX R B, KJELDSEN S E, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE) : a randomised trial against atenolol [ J ]. Lancet, 2002, 359 (9311): 995-1003.
  • 5VAN DE REE M A, HUISMAN M V, PRINCEN H M, et al. Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus [ J ] . Atherosclerosis, 2003, 166 (1) : 129-135.
  • 6CALO L, BIANCONI L, COLIVICCHI F, et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, con- trolled trial [J]. J Am Coll Cardiol, 2005, 45 (10) : 1723-1728.
  • 7SINGH B N, CONNOLLY S J, CRIJNS H J, et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter [J]. N Engl J Med, 2007, 357 (10) : 987-999.
  • 8DORIAN P, PINTER A, MANGAT I, et al. The effect of vemakalant ( RSD1235 ) , an investigational antiarrhythmic agent, on atrial electrophysiology in humans [J]. J Cardiovase Pharmaeol, 2007, 50 (1): 35-40.
  • 9SHIROSHITA-TAKESHITA A, SAKABE M, HAUGAN K, et al. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs[ J ]. Circulation, 2007, 115 (3): 310-318.
  • 10PAPPONE C, ROSANIO S, AUGELLO G, et al. Mortal- ity, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study [ J ]. J Am Coil Cardiol, 2003, 42 (2) : 185-197.

共引文献8

同被引文献36

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量：1398
  • 2彭彬,蒋学俊.单核细胞趋化蛋白-1与心力衰竭的关系研究进展[J].心血管病学进展,2007,28(4):570-572. 被引量：8
  • 3Groenveld H F,Crijns H J,Van den Berg M P,et al. The effect of rate control on quality of life in patients with perma- nent atrial fibrillation: data from the RACE lI (Rate Control Eficacv in Permanent Atrial Fibrillation ll)study [J]. ] Am Coll Cardiol, 2011, 58(17) : 1795-1803.
  • 4胡大一.心房颤动的流行病学及治疗现状.中国医学论坛报,2004,927.
  • 5Warm LS,Curtis AB,January CT,et al. 2011 ACCF / AHA / HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline):a report of theAmerican College of CardiologyFoundation/American Heart Assiation Task Force on Practice Guidelines. Circulation, 2011,123 : 104-123.
  • 6Fukumoto K, Kobayashi T, Tachibana K, ct al. Effect of amiodarone on the serum concentration / dose ratio of metoprolol in patients with cardiac arrhythmia [J]. Drug Metabolism and Pharmaeokinetics, 2006,21 (6) : 501-505.
  • 7Baker JG. The selectivity of beta-adreneptor antagonists at the human Betal, bata2 and beta3 adrenoceptors [J]. Br J Pharmacol, 2005. 144:317--322.
  • 8Van Gelder IC,Groenve|d HF,Crijns HJ,et al. Lenient venus strict rate control in patients with atrial fibrillation. N Engl J M ed, 2010,362: 1363.
  • 9刘丽娟,郑东诞,李树彬,潘德茂,王强,张玮,高修仁.高频左心房起搏制作兔慢性房颤模型及电生理特性研究[J].中山大学学报（医学科学版）,2009,30(6):723-727. 被引量：4
  • 10张澍,华伟,黄德嘉,王景峰,吴立群,杨杰孚,曹克将,黄从新,王方正,陈新,无.植入性心脏起搏器治疗——目前认识和建议（2010年修订版）[J].中华心律失常学杂志,2010,14(4):245-259. 被引量：86

引证文献5

二级引证文献19

新医学
2013年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部